| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA5201859
Max Phase: Preclinical
Molecular Formula: C22H23N3O
Molecular Weight: 345.45
Associated Items:
Representations
Canonical SMILES: CCCc1ccc2c(c1)nc(NCc1ccco1)n2Cc1ccccc1
Standard InChI: InChI=1S/C22H23N3O/c1-2-7-17-11-12-21-20(14-17)24-22(23-15-19-10-6-13-26-19)25(21)16-18-8-4-3-5-9-18/h3-6,8-14H,2,7,15-16H2,1H3,(H,23,24)
Standard InChI Key: ZHOQZNOPUNQORK-UHFFFAOYSA-N
Associated Targets(Human)
Short transient receptor potential channel 5 300 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 345.45 | Molecular Weight (Monoisotopic): 345.1841 | AlogP: 5.24 | #Rotatable Bonds: 7 |
| Polar Surface Area: 42.99 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
| #RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: | CX Basic pKa: 6.80 | CX LogP: 5.55 | CX LogD: 5.46 |
| Aromatic Rings: 4 | Heavy Atoms: 26 | QED Weighted: 0.50 | Np Likeness Score: -1.45 |
References
| 1. Chen L, Zhang Z, Tian H, Jiang S, Ji Y, Liu M, Shen J, Cao Z, Wang K.. (2022) Synthesis of AC1903 analogs as potent transient receptor potential canonical channel 4/5 inhibitors and biological evaluation., 68 [PMID:35653869] [10.1016/j.bmc.2022.116853] |
Source
Source(1):